Context Therapeutics Inc. · NASDAQ:CNTX
Blue Owl Capital Holdings LP's stake in Context Therapeutics Inc. fell to 3.19% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 12, 2026
Blue Owl Capital Holdings LP's stake in Context Therapeutics Inc. fell to 3.19%, 2,934,015 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).
- Stake
- 3.19%
- Shares
- 2,934,015
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Blue Owl Capital Holdings LP | 3.19% | 2,934,015 |
Source
Related
- Context Therapeutics Inc.
- Blue Owl Capital Holdings LP
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Feb 14, 2025
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026
- Schedule 13G · Octagon Capital Advisors LP · May 14, 2026